TC
AZN icon

TownSquare Capital’s AstraZeneca AZN Stock Holding History

TownSquare Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$265K Sell
1,344
-179
-12% -$34.5K 0.06% 209
2025
Q4 		$280K Sell
1,523
-606
-28% -$106K 0.06% 204
2025
Q3 		$327K Sell
2,129
-2,483
-54% -$376K 0.05% 276
2025
Q2 		$645K Sell
4,612
-36,539
-89% -$5.12M 0.06% 300
2025
Q1 		$6.05M Sell
41,151
-3,137
-7% -$454K 0.06% 281
2024
Q4 		$5.8M Buy
44,288
+1,103
+3% +$154K 0.07% 278
2024
Q3 		$6.73M Buy
43,185
+15,477
+56% +$2.5M 0.08% 245
2024
Q2 		$4.32M Buy
27,708
+4,058
+17% +$611K 0.06% 300
2024
Q1 		$3.2M Buy
23,650
+1,134
+5% +$150K 0.05% 345
2023
Q4 		$3.03M Buy
22,516
+7,778
+53% +$1.01M 0.05% 335
2023
Q3 		$2M Buy
14,738
+9,226
+167% +$1.26M 0.04% 404
2023
Q2 		$789K Buy
5,512
+1,078
+24% +$159K 0.01% 620
2023
Q1 		$616K Buy
4,434
+189
+4% +$25.4K 0.01% 609
2022
Q4 		$576K Buy
4,245
+2,262
+114% +$284K 0.01% 595
2022
Q3 		$217K Buy
+1,983
New +$252K 0.01% 672
2020
Q4 		– Sell
-1,921
Closed -$206K – 496
2020
Q3 		$206K Sell
1,921
-91
-5% -$10.1K 0.01% 396
2020
Q2 		$214K Sell
2,012
-1,084
-35% -$112K 0.01% 373
2020
Q1 		$321K Sell
3,096
-869
-22% -$81.8K 0.03% 323
2019
Q4 		$396K Buy
3,965
+29
+0.7% +$2.73K 0.03% 313
2019
Q3 		$368K Sell
3,936
-219
-5% -$19K 0.03% 355
2019
Q2 		$368K Sell
4,155
-464
-10% -$36.4K 0.04% 337
2019
Q1 		$373K Buy
4,619
+1,416
+44% +$112K 0.03% 321
2018
Q4 		$237K Buy
+3,203
New +$250K 0.03% 329

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

TownSquare Capital's AZN Position: Q1 2026 in Review

TownSquare Capital reduced its AstraZeneca (AZN) stake by 12% in Q1 2026, selling an estimated $34.5K and leaving 1,344 shares worth $265K. The position accounts for 0.06% of the portfolio, ranked #209.

TownSquare Capital first reported a position in AZN in Q4 2018 and has held it in 23 quarters since. The position peaked at $6.73M in Q3 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • TownSquare Capital held 1,344 shares of AstraZeneca worth $265K as of Q1 2026.
  • TownSquare Capital sold 179 AstraZeneca shares in Q1 2026, an estimated $34.5K.
  • AstraZeneca made up 0.06% of TownSquare Capital's portfolio in Q1 2026, its #209 holding.
  • TownSquare Capital first reported a position in AstraZeneca in Q4 2018 and has held it in 23 quarters since.
  • TownSquare Capital's AstraZeneca position peaked at $6.73M in Q3 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on TownSquare Capital's 13F filing for Q1 2026, filed 13 May 2026.